Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMicroRNAs as diagnostic and prognostic biomarkers in colorectal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerNon-coding landscapes of colorectal cancerThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsCirculating microRNA testing for the early diagnosis and follow-up of colorectal cancer patientsMicroRNAs in colorectal cancer: role in metastasis and clinical perspectivesAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.Identification and functional screening of microRNAs highly deregulated in colorectal cancerMicroRNA regulation network in colorectal cancer metastasisIntegrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes.Circulating miRNAs as new blood-based biomarkers for solid cancers.Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyCirculating miRNAs in cancer: from detection to therapy.The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.Regulation of cancer metastasis by cell-free miRNAs.Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.Parasite-derived microRNAs in host serum as novel biomarkers of helminth infectionUse of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.MicroRNAs as potential biomarkers in cancer: opportunities and challengesSignificance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer PatientsDifferential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.Need for rigor in design, reporting, and interpretation of transcriptomic biomarker studies.MicroRNAs as potential biomarkers in human solid tumors.Potential pitfalls in microRNA profilingCirculating miRNA profile in HCV infected serum: novel insight into pathogenesis.MiR-29a modulates the angiogenic properties of human endothelial cells.Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.miRNA: The nemesis of gastric cancer (Review).
P2860
Q26748881-36D5EA49-AF94-4CC9-9F1E-462BEFEA6DFDQ26751780-47B5BE10-5CD4-45A9-9E9A-286C038008ACQ26775610-02CACF0E-D8F6-408F-B4B3-C0D667479F0BQ26778014-D947C842-EF8C-4F64-A36E-774B47F1A867Q26825022-D098B986-A338-4C77-922E-864FEC0BEF5AQ26996424-460ECE59-BE74-40BC-895C-C2C0DFF60821Q27022292-6538ACEB-2F8B-4DFC-B1CC-C90C18E0D36AQ27024427-2D9F774B-0D65-4E94-AD7B-076E291E6DAFQ33654179-1FAF05FC-A519-4EAE-9FC5-572EB838B505Q33985952-1C800B15-6B8F-4938-AD16-D5869E61EA54Q34161573-C8DBA854-B2FD-4DAB-AA44-B8CA85AC5BBDQ34217210-D7191B1C-3359-42A0-B1E3-3325F4537522Q34331651-14CBB26B-9805-4FE3-8AF3-CE1429242FC5Q34512023-357B20D5-9151-44F3-8FFE-1721A4A7AA5CQ34533796-0941873B-6B33-4C4D-82B7-9FEFEE8B6427Q34603514-886D9D15-2FFE-4176-9C7A-2034BE3962ADQ34605730-803E70DF-B70B-4C88-910A-33BAA8052572Q34728385-4D86C5B6-3759-45E8-A6D2-E559B6D55A3EQ34806020-1CBD4A9F-F472-4D67-B09A-E4D167AEAD71Q34846142-A90766F2-55CA-4CB0-B1CE-DA3656FEAA0CQ35034340-DE765C56-544A-4FCA-8C95-7ED8F2923832Q35098328-2AD41DAF-221E-4454-A6F2-974C217023FDQ35109196-4EA8536A-7272-445B-B15D-24E0C7CB24F6Q35148262-F62FAC15-785A-4172-95BA-333382F696ECQ35196062-3BB6D9CD-7241-4C31-8D37-DF87CC8AB33DQ35203556-F75531D7-E512-46B3-A530-80AE6F017348Q35271157-F54A603B-650B-4B7B-96E7-A83BCC4D96BAQ35405060-B03242F9-8319-4058-818F-B9BE8CFF94DFQ35677900-B1EBFE5E-646C-4EB6-BBC8-F12A04003D34Q35742436-6D05DD95-DE5C-4D74-9D29-7C3C2E15E4FEQ36063908-34A03C2A-1CAF-47DB-8E97-10DEE2119BF1Q36152800-A04E0191-CE22-4A37-B95C-2683DAD9AF0DQ36414028-BD4D78DF-91C9-4AFB-AAE4-06972243B648Q36553661-C39952E9-2328-4CF0-A029-AE61ED7B2FCFQ36683715-91EE8FAE-919A-4D5C-9986-5DFA47676701Q36737114-7D43D8B2-2902-4D26-880F-6A66140716D6Q36822851-0BDBBB0A-3205-43BF-A510-EC043D751256Q36913739-E7E2476D-C588-4635-A172-0780A34E3254Q36942423-AAFD0518-01F9-4AB9-B49A-3BFC6C1CA94DQ37211784-38E1FC20-FCA5-4496-957D-B074B36F1066
P2860
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@en
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@nl
type
label
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@en
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@nl
prefLabel
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@en
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@nl
P1433
P1476
Serum microRNA-29a is a promis ...... f colorectal liver metastasis.
@en
P2093
Long-Gang Wang
P356
10.1016/J.CANEP.2011.05.002
P577
2011-10-21T00:00:00Z